These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 15265052)
1. A randomized, double blind study of the prophylactic effect of hyperbaric oxygen therapy on migraine. Eftedal OS; Lydersen S; Helde G; White L; Brubakk AO; Stovner LJ Cephalalgia; 2004 Aug; 24(8):639-44. PubMed ID: 15265052 [TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study. Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM; Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098 [TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study. Dodick DW; Mauskop A; Elkind AH; DeGryse R; Brin MF; Silberstein SD; Headache; 2005 Apr; 45(4):315-24. PubMed ID: 15836567 [TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues. Cady R; Schreiber C Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of botulinum toxin type A for the prophylaxis of episodic migraine headaches: a meta-analysis of randomized, double-blind, placebo-controlled trials. Shuhendler AJ; Lee S; Siu M; Ondovcik S; Lam K; Alabdullatif A; Zhang X; Machado M; Einarson TR Pharmacotherapy; 2009 Jul; 29(7):784-91. PubMed ID: 19558252 [TBL] [Abstract][Full Text] [Related]
6. Oral sumatriptan for the acute treatment of probable migraine: first randomized, controlled study. Tepper SJ; Cady R; Dodick D; Freitag FG; Hutchinson SL; Twomey C; Kuhn TA Headache; 2006 Jan; 46(1):115-24. PubMed ID: 16412159 [TBL] [Abstract][Full Text] [Related]
7. Intravenous dexamethasone vs placebo as adjunctive therapy to reduce the recurrence rate of acute migraine headaches: a multicenter, double-blinded, placebo-controlled randomized clinical trial. Donaldson D; Sundermann R; Jackson R; Bastani A Am J Emerg Med; 2008 Feb; 26(2):124-30. PubMed ID: 18272089 [TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin A in the prophylactic treatment of migraine--a randomized, double-blind, placebo-controlled study. Evers S; Vollmer-Haase J; Schwaag S; Rahmann A; Husstedt IW; Frese A Cephalalgia; 2004 Oct; 24(10):838-43. PubMed ID: 15377314 [TBL] [Abstract][Full Text] [Related]
9. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets. Sheftell FD; Dahlöf CG; Brandes JL; Agosti R; Jones MW; Barrett PS Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814 [TBL] [Abstract][Full Text] [Related]
10. Randomized, double-blind, placebo-controlled, proof-of-concept study of the cortical spreading depression inhibiting agent tonabersat in migraine prophylaxis. Goadsby PJ; Ferrari MD; Csanyi A; Olesen J; Mills JG; Cephalalgia; 2009 Jul; 29(7):742-50. PubMed ID: 19222510 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of carisbamate for the treatment of migraine in a randomized, double-blind trial. Cady RK; Mathew N; Diener HC; Hu P; Haas M; Novak GP; Headache; 2009 Feb; 49(2):216-26. PubMed ID: 19222595 [TBL] [Abstract][Full Text] [Related]
12. A double-blind, randomized, placebo-controlled comparison of botulinum toxin type a injection sites and doses in the prevention of episodic migraine. Saper JR; Mathew NT; Loder EW; DeGryse R; VanDenburgh AM; Pain Med; 2007 Sep; 8(6):478-85. PubMed ID: 17716321 [TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of hyperbaric oxygen therapy for the treatment of interstitial cystitis: a randomized, sham controlled, double-blind trial. van Ophoven A; Rossbach G; Pajonk F; Hertle L J Urol; 2006 Oct; 176(4 Pt 1):1442-6. PubMed ID: 16952654 [TBL] [Abstract][Full Text] [Related]
14. Rizatriptan 5 mg for the acute treatment of migraine in adolescents: results from a double-blind, single-attack study and two open-label, multiple-attack studies. Visser WH; Winner P; Strohmaier K; Klipfel M; Peng Y; McCarroll K; Cady R; Lewis D; Nett R; Headache; 2004 Oct; 44(9):891-9. PubMed ID: 15447698 [TBL] [Abstract][Full Text] [Related]
15. Acupuncture in migraine prevention: a randomized sham controlled study with 6-months posttreatment follow-up. Alecrim-Andrade J; Maciel-Júnior JA; Carnè X; Severino Vasconcelos GM; Correa-Filho HR Clin J Pain; 2008 Feb; 24(2):98-105. PubMed ID: 18209514 [TBL] [Abstract][Full Text] [Related]
16. Haloperidol in the acute treatment of migraine: a randomized, double-blind, placebo-controlled study. Honkaniemi J; Liimatainen S; Rainesalo S; Sulavuori S Headache; 2006 May; 46(5):781-7. PubMed ID: 16643581 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of sumatriptan tablets in migraineurs self-described or physician-diagnosed as having sinus headache: a randomized, double-blind, placebo-controlled study. Ishkanian G; Blumenthal H; Webster CJ; Richardson MS; Ames M Clin Ther; 2007 Jan; 29(1):99-109. PubMed ID: 17379050 [TBL] [Abstract][Full Text] [Related]
18. The effect of propranolol on glyceryltrinitrate-induced headache and arterial response. Tvedskov JF; Thomsen LL; Thomsen LL; Iversen HK; Williams P; Gibson A; Jenkins K; Peck R; Olesen J Cephalalgia; 2004 Dec; 24(12):1076-87. PubMed ID: 15566422 [TBL] [Abstract][Full Text] [Related]
19. Butterbur root extract and music therapy in the prevention of childhood migraine: an explorative study. Oelkers-Ax R; Leins A; Parzer P; Hillecke T; Bolay HV; Fischer J; Bender S; Hermanns U; Resch F Eur J Pain; 2008 Apr; 12(3):301-13. PubMed ID: 17659990 [TBL] [Abstract][Full Text] [Related]
20. Improvement in motor and cognitive impairment after hyperbaric oxygen therapy in a selected group of patients with cerebrovascular disease: a prospective single-blind controlled trial. Vila JF; Balcarce PE; Abiusi GR; Dominguez RO; Pisarello JB Undersea Hyperb Med; 2005; 32(5):341-9. PubMed ID: 16457083 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]